Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels Encouraging safety profile with no dose limiting...
FOSTER CITY, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio...
FOSTER CITY, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.15 | -3.25379609544 | 4.61 | 4.7324 | 4.165 | 2566285 | 4.43174496 | CS |
4 | -1.16 | -20.640569395 | 5.62 | 5.95 | 4.165 | 1912528 | 4.73093561 | CS |
12 | -2.6 | -36.8271954674 | 7.06 | 7.6299 | 4.165 | 1843007 | 5.77185267 | CS |
26 | -3.35 | -42.8937259923 | 7.81 | 11.4 | 4.165 | 1824213 | 7.36782286 | CS |
52 | -1.1 | -19.7841726619 | 5.56 | 11.4 | 4.165 | 1436969 | 7.23054649 | CS |
156 | -0.88 | -16.4794007491 | 5.34 | 14.0435 | 1.45 | 750103 | 7.19627929 | CS |
260 | -12.49 | -73.6873156342 | 16.95 | 28.36 | 1.45 | 588160 | 7.55793089 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
TCTMTCTM Kids IT Education Inc | US$ 0.764 (321.87%) | 731.1M |
NVDANVIDIA Corporation | US$ 120.07 (-3.67%) | 388.5M |
RIMEAlgorhythm Holdings Inc | US$ 0.02565 (5.12%) | 341.8M |
CLEUChina Liberal Education Holdings Ltd | US$ 0.1938 (30.77%) | 237.15M |
BHATBlue Hat Interactive Entertainment Technology | US$ 0.0355 (-11.25%) | 236.44M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約